TelyRx Holdings Inc.
TELY.TO
TSX
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -50.89% | -- | 95.74% | ||
| Total Depreciation and Amortization | -27.07% | -- | 525.00% | ||
| Total Amortization of Deferred Charges | 12.32% | -- | -- | ||
| Total Other Non-Cash Items | 590.18% | -- | -81.97% | ||
| Change in Net Operating Assets | -28.30% | -- | 74.83% | ||
| Cash from Operations | -208.43% | -- | 135.56% | ||
| Capital Expenditure | 68.85% | -- | -138.24% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 550.70% | -- | 57.77% | ||
| Cash from Investing | 328.03% | -- | -4.43% | ||
| Total Debt Issued | 407.30% | -- | -- | ||
| Total Debt Repaid | -8,236.04% | -- | 91.21% | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 1,208.84% | -- | -100.50% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 1,904.09% | -- | -111.74% | ||